The opposition was filed in May 2023 with the European Patent Office (EPO) by bioMerieux and a strawman representing other undisclosed firm against T2 Biosystems' granted European Patent No. 3 443 124 ...
T2 Biosystems, Inc. (NASDAQ:TTOO) (the "Company"), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today ...
ME Therapeutics to begin testing of first mRNA formulations from NanoVation Therapeutics collaboration: Vancouver, British Columbia Friday, September 20, 2024, 14:00 Hrs [IST] ME ...
The global microarray market size was valued at US$ 4.2 billion in 2022 and is estimated to reach US$ 8.4 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.8% during the forecast ...